A Randomized, Double-blinded, Multicenter, Phase Ⅲ Clinical Study of HLX22 (Recombinant Humanized Anti-HER2 Monoclonal Antibody Injection) in Combination With Trastuzumab and Chemotherapy (XELOX) Versus Trastuzumab and Chemotherapy (XELOX) With or Without Pembrolizumab for the First Line Treatment of Locally Advanced or Metastatic Gastroesophageal Junction and Gastric Cancer
A Randomized, Double-blinded, Multicenter, Phase Ⅲ Clinical Study of HLX22 (Recombinant Humanized Anti-HER2 Monoclonal Antibody Injection) in Combination With Trastuzumab and Chemotherapy (XELOX) Versus Trastuzumab and Chemotherapy (XELOX) With or Without Pembrolizumab for the First Line Treatment of Locally Advanced or Metastatic Gastroesophageal Junction and Gastric Cancer
This is a double-blind, randomized, multiregion, comparative phase Ⅲ clinical study designed to evaluate the efficacy and safety of HLX22 in combination with trastuzumab and chemotherapy as first-line treatment in patients with HER2-positive locally advanced/metastatic adenocarcinoma of the gastric and/or gastroesophageal junction (G/GEJ).Eligible subjects will be randomized to the two groups based on a 1:1 ratio. Enrolled subjects shall be treated with the study drug until the loss of clinical benefit, death, intolerable toxicity, withdrawal of informed consent, or other reasons specified by the protocol (whichever occurs first).
In experimental group: HLX22 (15 mg/kg) + trastuzumab + chemotherapy (XELOX) ± placebo (for pembrolizumab), once every 3 weeks (Q3W).
In control group: Placebo (for HLX22) + trastuzumab + chemotherapy (XELOX) ± pembrolizumab, Q3W.
Inclusion Criteria:
Exclusion Criteria:
ying_li1@henlius.com+86 18810366427
Los Alamitos, California 90720, United States
Iowa City, Iowa 52242, United States
Sayre, Pennsylvania 18840, United States
Buenos Aires, Buenos Aires B2700, Argentina
Viedma, Río Negro Province 8500, Argentina
Cordoba, Santa Fe Province 2000, Argentina
Cordoba, Santa Fe Province X5008HHW, Argentina
Sunshine Coast, Queensland 4556, Australia
Gosford, Sydney 2250, Australia
Belo Horizonte, Minas Gerais 30130 090, Brazil
Porto Alegre, Rio Grande do Sul 90035-903, Brazil
Porto Alegre, Rio Grande do Sul 90110-270, Brazil
Santa Maria, Rio Grande Do Sul (RS) 97015-450, Brazil
Hangzhou, China
Tbilisi, 114, Georgia
Athens, 11522, Greece
Naples, 80131, Italy
Rozzano, 20089, Italy
San Giovanni Rotondo, 71013, Italy
Udine, 33100, Italy
Akashi-shi, Hyōgo, Japan
Chuo Ku, Tokyo, Japan
Chuo-ku Osaka-shi, Japan
Izumi-shi, Japan
Kasama-shi, Japan
Osaki-shi, Japan
Takatsuki-shi, Japan
Toyonaka-shi, Japan
Słupsk, Poland
Adana, Turkey (Türkiye)
Erzurum, Turkey (Türkiye)